Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(11%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
1
11%
Ph not_applicable
3
33%
Ph phase_2
4
44%
Ph phase_4
1
11%

Phase Distribution

1

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Other(1)

Detailed Status

Completed6
Active, not recruiting1
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

active_not_recruiting111%
unknown111%
not_yet_recruiting111%
completed667%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9